Star Combo Pharma

Star Combo Pharma EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Star Combo Pharma (S66.AX) as of Nov 6, 2026 is -231,096.00 AUD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -237,982.00 AUD — a change of -2.89% (higher).

EBITDA

-231,096.00AUD

YoY

-2.89%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Star Combo Pharma is 2026 -231,096.00 AUD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Star Combo Pharma was 2025 -237,982.00 AUD. It decreases by -2.89% higher compared to the previous year.

The Star Combo Pharma EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
-2.31 M AUD
Jan 1, 2020
-512,544.00 AUD
Jan 1, 2021
-7.23 M AUD
Jan 1, 2022
-445,593.00 AUD
Jan 1, 2023
961,779.00 AUD
Jan 1, 2024
723,435.00 AUD
Jan 1, 2025
-237,982.00 AUD
Jan 1, 2026
-231,096.00 AUD
The Star Combo Pharma EBITDA history
YEAREBITDAYoY
-231,096.00AUD-2.89%
-237,982.00AUD-132.90%
723,435.00AUD-24.78%
961,779.00AUD-315.84%
-445,593.00AUD-93.83%
-7.23 MAUD+1,310.14%
-512,544.00AUD-77.82%
-2.31 MAUD+11.75%
-2.07 MAUD-178.70%
2.63 MAUD-21.83%
3.36 MAUD+865.40%
348,244.00AUD-41.04%
590,672.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Star Combo Pharma Stock analysis

What does Star Combo Pharma do? Star Combo Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Star Combo Pharma stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Star Combo Pharma is -231,096.00 AUD in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Star Combo Pharma changed from -237,982.00 AUD to -231,096.00 AUD, representing a -2.89% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Star Combo Pharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Star Combo Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Star Combo Pharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Star Combo Pharma